# FDA Inspection 1202529 - CSL Plasma Inc. - March 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/69decd55-268d-4473-a145-3ba71d4a6ecb
Source feed: FDA_Inspections

> FDA Inspection 1202529 for CSL Plasma Inc. on March 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202529
- Company Name: CSL Plasma Inc.
- Inspection Date: 2023-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1202529 - 2023-03-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/22680829-9fb0-40bf-a540-0dbfa6538e1b)
- [FDA Inspection 1024103 - 2017-08-16](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/119c779d-c1ec-4ad5-8e9f-71058fd116a5)
- [FDA Inspection 910816 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/f4df6c22-aa26-4bc8-ab83-aa7533f0a8b4)

Company: https://www.keypedia.com/companies/csl-plasma-inc/1d362704-5321-484d-a260-9d04dd53d0c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d